Amy Simon
Förmögenhet: 3 M $ per 2026-06-30
Förmögenhet: 3 M $ per 2026-06-30
Amy Simon is currently Chief Medical Officer at Beam Therapeutics, Inc. since 2021.
Formerly, Dr. Simon was Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc., and held professor positions at Tufts University and the Graduate School of Biomedical Sciences.
Education includes an undergraduate degree from Harvard University and a doctorate from Tufts University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 0,08 % | 2026-07-27 | 85 696 ( 0,08 % ) | 3 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| BEAM THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-03-15 |
| Företag | Position | Slut |
|---|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Graduate School of Biomedical Sciences | Företagsledare/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Graduate School of Biomedical Sciences |
Välj din utgåva
All finansiell information anpassad till den nationella nivån